Analysts anticipate Rigel Pharmaceuticals to report an earnings per share (EPS) of $1.41.
Rigel Pharmaceuticals bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Earnings History Snapshot
During the last quarter, the company reported an EPS beat by $0.54, leading to a 1.15% increase in the share price on the subsequent day.
Here's a look at Rigel Pharmaceuticals's past performance and the resulting price change:
Quarter
Q1 2025
Q4 2024
Q3 2024
Q2 2024
EPS Estimate
0.09
0.55
0.06
-0.29
EPS Actual
0.63
0.80
0.70
-0.06
Price Change %
1.0%
-8.0%
43.0%
6.0%
Rigel Pharmaceuticals Share Price Analysis
Shares of Rigel Pharmaceuticals were trading at $21.91 as of August 01. Over the last 52-week period, shares are up 140.84%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Analyst Observations about Rigel Pharmaceuticals
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into ...
